| Date | Company / Note | Sector | Rating | Target | Implied | |
|---|---|---|---|---|---|---|
| 8 Sep 2026 | Sun Pharmaceutical Industries NSE: SUNPHARMA · BSE: 524715 · Initiation | Pharmaceuticals | UNDERWEIGHT | ₹1,500 | −21% | Open → |
| 28 Aug 2026 | Wipro Ltd NSE: WIPRO · Bear Case | IT Services | UNDERWEIGHT | ₹155 | −11.9% | Open → |
| 28 Aug 2026 | Nestlé India Ltd NSE: NESTLEIND · Initiation | Consumer Staples — Packaged Foods | UNDERWEIGHT | ₹1,150 | −20.6% | Open → |
| 28 Aug 2026 | Torrent Pharmaceuticals NSE: TORNTPHARM · BSE: 500420 · JB Chemicals Synergies | Pharmaceuticals — Branded Generics | OVERWEIGHT | ₹5,800 | +16% | Open → |
| 27 Aug 2026 | BSE Ltd NSE: BSE · Bull Thesis | Financial Exchanges | BUY | ₹4,400 | +32% | Open → |
| 27 Aug 2026 | BSE Ltd NSE: BSE · Valuation Check | Financial Exchanges | UNDERWEIGHT | ₹2,400 | −28% | Open → |
| 14 Sep 2026 | Titan Company Ltd NSE: TITAN · BSE: 500114 · Bear Case | Consumer Discretionary — Jewellery & Lifestyle | UNDERWEIGHT | ₹3,800 | −24% | Open → |
Ratings: BUY/OVERWEIGHT — expected outperformance of the relevant benchmark over 6–12 months. UNDERWEIGHT — expected underperformance. Where we publish opposing notes on the same company (e.g. BSE Ltd), each is dated and stands on its own evidence base; read them as a structured debate, not a hedge. This document is an AI-generated research note prepared for information and illustration only. It is not investment advice, not an offer to transact, and is not affiliated with or endorsed by any broker or bank. Figures are compiled from third-party public sources that may be delayed or revised. Equity investments carry risk of loss; consult a SEBI-registered investment adviser before acting.